MJBizDaily
DEA selects only cannabis foes to participate in marijuana rescheduling hearing
Latest Posts
Glass House Brands goes medical-cannabis only in preparation for uplisting – and export
California-based mega-cultivator Glass House Brands applied for listing on the New York Stock Exchange after shifting its assets around to go medical cannabis-only, the company said.
News June 18Federal cannabis rescheduling may not apply in Washington, regulator warns
Since cannabis operators in Washington are licensed under a single-tier system, federal medical cannabis rescheduling may not be much help.
News June 17Illinois folds hemp THC into regulated cannabis system, but drinks unclear
Gov. JB Pritzker had threatened to ban intoxicating hemp products entirely if lawmakers failed to establish regulations for the products.
News June 17The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator
As cannabis shoppers become more educated, seed brands are no longer just selling genetics — they are shaping loyalty, discovery, and the next wave of premium cultivation culture.
June 9Michigan’s top cannabis regulator elected president of CANNRA
Regulators from Virginia, Illinois, Hawaii, Connecticut, Missouri and Iowa also will serve on CANNRA’s 2026-27 board.
News June 16Virginia adult-use cannabis sales to begin July 2027 under new deal
License caps and tax rates both set in compromise that will see sales begin July 1, 2027.
News June 16Canopy Growth reports big jump in medical cannabis revenue
Canopy’s medical cannabis net revenue in the fourth quarter was $25.3 million. Its international revenue was $8.6 million.
News June 15Texas court reinstates hemp rules, enforcement still unclear
The decision does not settle the broader lawsuit, but it removes a lower-court block that paused enforcement of portions of the regulations.
News June 12Trulieve is first US cannabis company to trade on NYSE
CEO Kim Rivers called the listing a turning point for the cannabis sector. Analysts predict the company will break even in the next year.
News June 11Nabis CEO on the future of interstate cannabis commerce post-rescheduling
Vince Ning says the question of whether reclassifying medical marijuana opens state borders to cannabis products remains largely unsettled.
News June 11














